Compare RCUS & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCUS | HE |
|---|---|---|
| Founded | 2015 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2018 | 1994 |
| Metric | RCUS | HE |
|---|---|---|
| Price | $23.65 | $13.56 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $31.90 | $13.25 |
| AVG Volume (30 Days) | 798.2K | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 106.32 |
| EPS | N/A | ★ 0.18 |
| Revenue | $247,000,000.00 | ★ $3,086,896,000.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $45.62 | $4.06 |
| P/E Ratio | ★ N/A | $75.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.92 | $10.15 |
| 52 Week High | $28.72 | $17.33 |
| Indicator | RCUS | HE |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 35.64 |
| Support Level | $22.61 | $13.15 |
| Resistance Level | $24.33 | $13.93 |
| Average True Range (ATR) | 1.05 | 0.45 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 34.06 | 16.57 |
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.